1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow MP 412: new trials by email Literature Review of MP 412 trials Research Report on MP 412
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients AV-412 - Advanced Cancer, Refractory Cancer | Phase 1 | Completed | AVEO Pharmaceuticals, Inc. | 37 | 2007-10-01 | 2011-10-04 |
| Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies AV-412 - Tumor | Phase 1 | Terminated | AVEO Pharmaceuticals, Inc. | 27 | 2006-10-01 | 2011-10-04 |
Neoplasms (2)
AVEO Pharmaceuticals, Inc. (2)
United States (2) · Argentina (1)
Carmen S. Puparelli, MD (1) · Justina L Martinez, MD (1) · Manuel Hidalgo, MD, PhD (1) · Pankaj Bhargava, M.D. (1)